Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Control of dopamine communication by opioids: glutamate enters the discussion
    Published on 2023-07-27
    3 years ago
  • Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl
    Published on 2023-07-27
    3 years ago
  • Assisting schizophrenia diagnosis using clinical electroencephalography and interpretable graph neural networks: a real-world and cross-site study
    Published on 2023-07-25
    3 years ago
  • The orexin neurotransmitter system as a target for medication development for opioid use disorder
    Published on 2023-07-25
    3 years ago
  • Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence
    Published on 2023-07-25
    3 years ago
  • Correction to: Pathways link environmental and genetic factors with structural brain networks and psychopathology in youth
    Published on 2023-07-25
    3 years ago
  • Puerarin attenuates valproate-induced features of ASD in male mice via regulating Slc7a11-dependent ferroptosis
    Published on 2023-07-25
    3 years ago
« Previous 1 … 118 119 120 121 122 … 143 Next »
Journal of Psychopharmacology
  • Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model
    Published on 2020-05-20
    6 years ago
  • Effect of antidepressant drugs on the brain sphingolipid system
    Published on 2020-05-14
    6 years ago
  • Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects
    Published on 2020-04-29
    6 years ago
  • Divergent pathways mediate 5-HT1A receptor agonist effects on close social interaction, grooming and aggressive behaviour in mice: Exploring the involvement of the oxytocin and vasopressin systems
    Published on 2020-04-21
    6 years ago
  • Treatment with slow-releasing hydrogen sulfide donors inhibits the nociceptive and depressive-like behaviours accompanying chronic neuropathic pain: Endogenous antioxidant system activation
    Published on 2020-04-21
    6 years ago
  • trans-Resveratrol ameliorates anxiety-like behaviors and neuropathic pain in mouse model of post-traumatic stress disorder
    Published on 2020-04-20
    6 years ago
  • Clozapine use – has practice changed?
    Published on 2020-04-16
    6 years ago
« Previous 1 … 118 119 120 121 122 … 150 Next »
European Neuropsychopharmacology
  • P.110 The matricellular protein hevin is overexpressed in alcoholism: a study in postmortem human brain.
    Published on 2021-02-26
    5 years ago
  • P.329 State anxiety induced by THC and CBD does not change after correcting for baseline anxiety levels
    Published on 2021-02-26
    5 years ago
  • P.111 Peripheral serotonin influences brain functions: focus on neuroplasticity and glucocorticoid genomic pathway
    Published on 2021-02-26
    5 years ago
  • P.330 Associations between depression and brain structure across the lifespan: results from the European Lifebrain consortium
    Published on 2021-02-26
    5 years ago
  • P.205 White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study
    Published on 2021-02-26
    5 years ago
  • P.222 Chronic injections of 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine induce tolerance in rats
    Published on 2021-02-26
    5 years ago
  • P.206 Altered pain responding in a model of autism associated with changes in endocannabinoid system-related gene expression
    Published on 2021-02-26
    5 years ago
« Previous 1 … 118 119 120 121 122 … 168 Next »

   Pharma Pub